These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7250460)

  • 1. Mast cells in Behçet's disease: ultrastructural and histamine content studies.
    Lichtig C; Haim S; Gilhar A; Hammel I; Ludatscher R
    Dermatologica; 1981; 162(3):167-74. PubMed ID: 7250460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quantification and significance of mast cells in lesions of Behçet's disease.
    Lichtig C; Haim S; Hammel I; Friedman-Birnbaum R
    Br J Dermatol; 1980 Mar; 102(3):255-9. PubMed ID: 7370173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin hyperreactivity response (pathergy) in Behçet's disease.
    Gilhar A; Winterstein G; Turani H; Landau J; Etzioni A
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):547-52. PubMed ID: 2778116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of lesions in Behçet's disease.
    Haim S
    Dermatologica; 1979; 158(1):31-7. PubMed ID: 367842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructure of mast cells in the iris of cases of Behçet's disease.
    Nii S; Yasuda I; Mimura Y; Hoki T; Yuasa T
    Biken J; 1974 Sep; 17(3):121-5. PubMed ID: 4455187
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrastructural localization of histamine in human basophils and mast cells; changes associated with anaphylactic degranulation and recovery demonstrated with a diamine oxidase-gold probe.
    Dvorak AM
    Allergy; 1997; 52(34 Suppl):14-24. PubMed ID: 9188950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 protein in active skin lesions of Behçet's disease.
    Senturk N; Yildiz L; Sullu Y; Kandemir B; Turanli AY
    Int J Dermatol; 2001 Dec; 40(12):747-50. PubMed ID: 11903667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histamine release from basophils in Behçet's syndrome].
    Yoshihira A
    Ryumachi; 1985 Nov; 25(5):348-54. PubMed ID: 2421417
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mucocutaneous involvement in Behçet's disease].
    Touraine R
    J Mal Vasc; 1988; 13(3):220-1. PubMed ID: 3171404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mast cell activation using diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry.
    Dvorak AM; Morgan ES; Monahan-Earley RA; Estrella P; Schleimer RP; Weller PF; Tepper RI; Lichtenstein LM; Galli SJ
    Int Arch Allergy Immunol; 1995; 107(1-3):87-9. PubMed ID: 7542108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dural mast cells: source of contaminating histamine in analyses of mouse brain histamine levels.
    Orr EL
    J Neurochem; 1984 Nov; 43(5):1497-9. PubMed ID: 6491664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogold ultrastructural techniques identify subcellular sites of chymase, Charcot-Leyden crystal protein, and histamine in basophils and mast cells.
    Dvorak AM
    Chem Immunol Allergy; 2005; 85():89-97. PubMed ID: 15970655
    [No Abstract]   [Full Text] [Related]  

  • 13. Histamine content of peritoneal and tissue mast cells of growing rats.
    Enerbäck L; Wingren U
    Histochemistry; 1980; 66(2):113-24. PubMed ID: 7390877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP 60 expression in mucocutaneous lesions of Behçet's disease.
    Ergun T; Ince U; Ekşioğlu-Demiralp E; Direskeneli H; Gürbüz O; Gürses L; Aker F; Akoğlu T
    J Am Acad Dermatol; 2001 Dec; 45(6):904-9. PubMed ID: 11712037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic manifestation of Behçet's disease.
    Lee ES; Bang D; Lee S
    Yonsei Med J; 1997 Dec; 38(6):380-9. PubMed ID: 9509907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous fibrinolytic potential, tPA dependent, is reduced in Behçet's disease.
    Lotti T; Matucci-Cerinic M
    Br J Dermatol; 1989 Dec; 121(6):713-6. PubMed ID: 2514783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural enzyme-affinity-gold and inhibitor-gold techniques identify subcellular sites of histamine and heparin in basophils and mast cells.
    Dvorak AM
    Chem Immunol Allergy; 2005; 85():98-134. PubMed ID: 15970656
    [No Abstract]   [Full Text] [Related]  

  • 18. Differentiation and activity of mast cells following immunization in cultures of lymph-node cells.
    Ginsburg H; Nir I; Hammel I; Eren R; Weissman BA; Naot Y
    Immunology; 1978 Sep; 35(3):485-502. PubMed ID: 700779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histohogical and direct immunofluorescence study of cutaneous hyperreactivity in Behçet's disease.
    Haim S; Sobel JD; Friedman-Birnbaum R; Lichtig C
    Br J Dermatol; 1976 Dec; 95(6):631-6. PubMed ID: 1009009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic study of cutaneous lesions in Behçet's syndrome.
    Chun SI; Su WP; Lee S
    J Dermatol; 1990 Jun; 17(6):333-41. PubMed ID: 2384635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.